Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Offerings

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • News
  • Offerings

Reported Late Wednesday, Iveric Bio Announces Pricing Of $300M Public Offering Of 13,350,000 Shares Of Common Stock At A Price Of $22.50/Share

By Benzinga Newsdesk
December 1, 2:12 AM
IVERIC bio, Inc. (NASDAQ:ISEE) (the "Company"), today announced the pricing of an upsized underwritten public offering of 13,350,000 shares of its common stock at a price to the public of $22.50 per share, less underwriting discounts and commissions.

ISEE

Read More
2 minute read
  • News
  • Offerings

Intellia Therapeutics Announces Pricing Of ~$300M Public Offering Of 6,550,219 Shares Of Common Stock At A Price Of $45.80/Share

By Benzinga Newsdesk
December 1, 2:09 AM
Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing potentially curative therapies leveraging CRISPR-based technologies, announced today the pricing of an

NTLA

Read More
2 minute read
  • News
  • Offerings

Reported Late Wednesday, Aura Biosciences Announces Pricing Of $80.4M Public Offering Of 6.7M Shares Of Common Stock At A Price Of $12/Share

By Benzinga Newsdesk
December 1, 2:07 AM
Aura Biosciences, Inc. ("Aura") (NASDAQ:AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced the

AURA

Read More
1 minute read
  • News
  • Offerings

MSP Recovery Files Prospectus Relates To Offer, Sale From Time To Time By Selling Securityholders Of Up To 67.4M Shares Of Class A Common Stock

By Michael Horton
November 30, 6:17 PM
-SEC Filing

MSPR

Read More
1 minute read
  • News
  • Offerings

Shoals Technologies Files For Offering Of 2M Shares Of Common Stock By Co.

By Michael Horton
November 30, 6:12 PM
-SEC Filing

SHLS

Read More
1 minute read
  • News
  • Offerings

Diamondback Energy Files Prospectus Relates To Proposed Resale From Time To Time Of Up To 5.9M Shares Of Common Stock By Selling Stockholders

By Michael Horton
November 30, 6:05 PM
-SEC Filing

FANG

Read More
2 minute read
  • News
  • Offerings

FREYR Battery Announces Public Offering of 13.5M Ordinary Shares, No Terms Disclosed

By Michael Horton
November 30, 6:03 PM
FREYR Battery (NYSE:FREY) ("FREYR"), a developer of clean, next-generation battery cell production capacity, today announced that it plans to make a public offering of 13,500,000 of its Ordinary Shares, without

FREY

Read More
1 minute read
  • General
  • News
  • Offerings
  • Small Cap

Aspen Aerogels Arranges Funds For Construction Of Statesboro Facility Via Equity Offering, Loan

By Shivani Kumaresan
November 30, 11:28 AM
Aspen Aerogels Inc (NYSE:ASPN) has priced its upsized public offering of 25.3 million shares at $9.50 per share. In addition, the…

ASPN

Read More
2 minute read
  • News
  • Offerings

OncoSec Announces Pricing Of $3.5M Public Offering

By Benzinga Newsdesk
November 30, 10:19 AM
OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a clinical-stage biotechnology company focused on developing intratumoral immunotherapies to stimulate the patient's own immune system to target and eradicate cancer, today announced the pricing of its "reasonable best effo

ONCS

Read More
1 minute read
  • News
  • Offerings

AST SpaceMobile To Sell 13,636,364 Shares Of Common Stock To Public At $5.50/Share

By Bill Haddad
November 30, 8:07 AM
AST SpaceMobile, Inc. (NASDAQ:ASTS) (the "Company" or "AST SpaceMobile") announced today the pricing of its previously announced public offering of its Class A common stock, par

ASTS

Posts pagination

Previous 1 … 122 123 124 … 166 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service